NEWS

August 29th 2019

Des macrophages, des souris et des hommes…Le Pr Stanislas Goriely vient d’obtenir un Win2Wal pour un ambitieux programme de recherche en immuno-oncologie. Au cœur de ce projet, des souris « humanisées » qui vont aider les chercheurs à mieux c...

News

August 29th 2019

Des macrophages, des souris et des hommes…Le Pr Stanislas Goriely vient d’obtenir un Win2Wal pour un ambitieux programme de recherche en immuno-oncologie. Au cœur de ce projet, des souris « humanisées » qui vont aider les chercheurs à mieux c...

News

August 29th 2019

Of macrophages, mice and men…Professor Stanislas Goriely has been awarded a grant as part of the WIN²WAL programme for his ambitious research project in immuno-oncology. At the heart of the project are ‘humanised’ mice that will...

News

August 29th 2019

Passer de la recherche académique à la spin-offButterFly DrugDevBooster est un nouveau programme de maturation proposé aux chercheurs par BioPark Incubator. Son objectif : favoriser et accélérer la transition entre la recherche académique et la cr...

News

August 29th 2019

Passer de la recherche académique à la spin-offButterFly DrugDevBooster est un nouveau programme de maturation proposé aux chercheurs par BioPark Incubator. Son objectif : favoriser et accélérer la transition entre la recherche académique et la cr...

News

August 29th 2019

From academic research to spin-offsButterfly DrugDevBooster is a new BioPark Incubator nurturing programme dedicated to researchers. Its goal is to promote and accelerate the transition from academic research to spin-off creation.From...

News

EVENTS

August 15th 2019

Coolerr Bags InformationPromethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patie...

15.08.2019 / 12:00 > 4:00 PM 58 Greta Street

Events

August 14th 2019

PROMETHERA BIOSCIENCES ANNOUNCES LATE-BREAKING DATA PRESENTATIONPromethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patie...

14.08.2019 / 7:00 > 12:00 PM ULiège - UMONS

Events

August 1st 2019

UMONS, ULB, ULG INAUGURATE THE MASS SPECTROMETRY PLATFORM MS-QUANTAMasthercell announces today that it has signed a lease agreement for a 5.700 m2 facility located in Gosselies. The new facility will become a state-of-the-art manufacturing and production site designe...

01.08.2019 / 12:00 > 4:00 PM ULiège - UMONS

Events